See also:
» 12.04.2010 - Africa's mobile money venture in patenting legal action
» 25.03.2010 - SA’s business eyeing oil in Uganda
» 25.03.2010 - Banks cut prime rates
» 17.03.2010 - Sweden to help SA develop clean energy
» 17.03.2010 - SA bank sign deal to access fingerprint data
» 08.03.2010 - SA opposition demands probe into Zuma
» 04.03.2010 - Britain no yet convinced to lift Zim sanctions
» 03.03.2010 - More black-outs for SA after World Cup

China wholesale online through

Houlihan's coupons

Finn autentiske matoppskrifter fra hele verden på
Gazpacho Børek Kartoffelsalat Taboulé Gulasj Albóndigas Cevapi Rougaille Japrak sarma Zwiebelbrot Klopse Giouvetsi Paella Pljeskavica Pica pau Pulpo a la gallega Flammkuchen Langosj Tapenade Chatsjapuri Pasulj Lassi Kartoffelpuffer Tortilla Raznjici Knödel Lentejas Bœuf bourguignon Korianderchutney Brenneslesuppe Proia Sæbsi kavurma Sardinske calamares

Autentiske matoppskrifter fra hele verden finner du på
Réunion Portugal Aserbajdsjan Serbia Tyskland Seychellene Bosnia Spania Libanon Belgia India Kroatia Hellas Italia Ungarn Komorene Georgia Mauritius Østerrike Romania Frankrike

South Africa
Economy - Development | Health

Little enthusiasm for generic AIDS drug plans in South Africa

afrol News, 2 July - A second agreement by pharmaceutical giant GlaxoSmithKline (GSK) to allow generic AIDS drugs in South Africa has been met with little enthusiasm. "GSK already has a South Africa generic AIDS drug deal that has failed to produce one pill," comment AIDS activists.

The Los Angeles-based AIDS Healthcare Foundation (AHF) - which operates free HIV treatment clinics in South Africa and Uganda - today issued a critical statement regarding yesterday's news that GlaxoSmithKline (GSK) has penned a second agreement to allow generic AIDS drugs in South Africa.

The pharmaceutical company granted voluntary licenses for two of its most-selling drugs to the South African generic manufacturer Thembalami. This grant however came too late for Thembalami to bid in this year's state antiretroviral procurement as the drugs yet are to be registered in South Africa.

AHF President Michael Weinstein today recalled the failure in Glaxo's generic AIDS drug deal for South Africa so far. "This simply reinvents a broken wheel," said Mr Weinstein, referring to the new deal announced yesterday.

Yesterday's announcement was not breaking any new ground, "but replicates failed policy," Mr Weistein added. "We call on GSK to finally do the right thing and create a genuinely safe environment for generic production."

Glaxo should announce - as Roche had already done - that it will forego any legal action enforcing AIDS drug patents in sub-Saharan Africa and other resource-poor regions facing high HIV infection rates, the US-based AIDS activists demanded.

The British-based pharmaceutical company can look back on a tough week regarding its AIDS drug policies, provoking protests from a large number of players. On Wednesday, it was known that Glaxo had dropped out of an AIDS drug test series for the developing world, sponsored by the US National Institutes of Health.

Glaxo had pulled out of the trials after the company had failed to prevent the testing of a competing company's AIDS drugs. The pharmaceutical giant was immediately fiercely criticised by members of the US Congress for having "attempted to pressure researchers to drop this comparison 'as a quid pro quo for providing the drug'."

The US government sponsored scientific study is to establish which combination of AIDS drugs is best fitted to keep HIV infected alive in the developing world. For the first time, drug combinations from different producers were to be tested - in contrast to the industry-sponsored studies looking into combinations of drugs made by a single producer.

The study was also to take special considerations regarding the health sector in developing countries. Among other countries, special attention is to be given to conditions in Malawi, South Africa and Zimbabwe.

After the firece criticism from the US Congress, Glaxo spokeswoman Nancy Pekarek later on Wednesday bowed into pressure and said the company would resume its participation in the study.

A short time after the disastrous PR resulting from Glaxo's short-lived withdrawal from the study, the UK-based company announced it had granted voluntary licenses for two of its antiretrovirals – AZT and 3TC – to the South African generic manufacturer Thembalami.

However, according to the British charity NAM, Glaxo's announcement "comes too late" for Thembalami to bid in the first round of antiretroviral procurement, announced by the South African government in March. Glaxo last year was charged with overpricing by the South African Competition Commission and thus agreed to grant voluntary licenses to local companies for generic drugs, while only requiring a royalty of 5 percent or less.

- Create an e-mail alert for South Africa news
- Create an e-mail alert for Economy - Development news
- Create an e-mail alert for Health news

    Printable version

On the Afrol News front page now

Rwanda succeeds including citizens in formal financial sector

afrol News - It is called "financial inclusion", and it is a key government policy in Rwanda. The goal is that, by 2020, 90 percent of the population is to have and actively use bank accounts. And in only four years, financial inclusion has doubled in Rwanda.

Famine warning: "South Sudan is imploding"

afrol News - The UN's humanitarian agencies now warn about a devastating famine in Sudan and especially in South Sudan, where the situation is said to be "imploding". Relief officials are appealing to donors to urgently fund life-saving activities in the two countries.
Panic in West Africa after Ebola outbreak in Guinea

afrol News - Fear is spreading all over West Africa after the health ministry in Guinea confirmed the first Ebola outbreak in this part of Africa. According to official numbers, at least 86 are infected and 59 are dead as a result of this very contagious disease.
Ethiopia tightens its already strict anti-gay laws

afrol News - It is already a crime being homosexual in Ethiopia, but parliament is now making sure the anti-gay laws will be applied in practical life. No pardoning of gays will be allowed in future, but activist fear this only is a signal of further repression being prepared.
Ethiopia plans Africa's biggest dam

afrol News / Africa Renewal - Ethiopia's ambitious plan to build a US$ 4.2 billion dam in the Benishangul-Gumuz region, 40 km from its border with Sudan, is expected to provide 6,000 megawatts of electricity, enough for its population plus some excess it can sell to neighbouring countries.

front page | news | countries | archive | currencies | news alerts login | about afrol News | contact | advertise | español 

©  afrol News. Reproducing or buying afrol News' articles.

   You can contact us at